Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)
India
· Delayed Price · Currency is INR 30.31
-1.19 (-3.78%)
At close: Mar 9, 2026
BOM:524396 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 5.58 | 7.09 | 5.6 | 6.98 | 12.41 | Upgrade
|
| Depreciation & Amortization | - | 3.8 | 3.99 | 4.29 | 4.28 | 4.12 | Upgrade
|
| Other Operating Activities | - | 0.58 | 2.34 | -0.54 | 0.51 | 0.73 | Upgrade
|
| Change in Accounts Receivable | - | -52.86 | -125.26 | -133.29 | 100.44 | 124.91 | Upgrade
|
| Change in Inventory | - | -7.92 | -13.36 | 0.8 | 30.51 | -26.52 | Upgrade
|
| Change in Accounts Payable | - | 34.33 | 149.05 | 120.54 | -152.56 | -100.66 | Upgrade
|
| Change in Other Net Operating Assets | - | -2.74 | 0.09 | 1.48 | 7.64 | -3.88 | Upgrade
|
| Operating Cash Flow | - | -19.24 | 23.94 | -1.12 | -2.2 | 11.11 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | 24.23% | Upgrade
|
| Capital Expenditures | - | -1 | -0.23 | -0.11 | -0.7 | -5.67 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 4.71 | Upgrade
|
| Investing Cash Flow | - | -1 | -0.23 | -0.11 | -0.7 | -0.96 | Upgrade
|
| Long-Term Debt Issued | - | 0.32 | - | 0.58 | 0.35 | - | Upgrade
|
| Total Debt Issued | - | 0.32 | - | 0.58 | 0.35 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -7.62 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.83 | - | - | - | Upgrade
|
| Total Debt Repaid | - | - | -0.83 | - | - | -7.62 | Upgrade
|
| Net Debt Issued (Repaid) | - | 0.32 | -0.83 | 0.58 | 0.35 | -7.62 | Upgrade
|
| Other Financing Activities | - | -0.37 | -0.42 | -0.43 | -0.41 | -0.68 | Upgrade
|
| Financing Cash Flow | - | -0.05 | -1.25 | 0.15 | -0.06 | -8.3 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | - | Upgrade
|
| Net Cash Flow | - | -20.28 | 22.46 | -1.07 | -2.96 | 1.85 | Upgrade
|
| Free Cash Flow | - | -20.24 | 23.71 | -1.22 | -2.9 | 5.44 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -20.84% | Upgrade
|
| Free Cash Flow Margin | - | -6.03% | 5.87% | -0.41% | -1.29% | 1.52% | Upgrade
|
| Free Cash Flow Per Share | - | -1.24 | 1.46 | -0.07 | -0.18 | 0.33 | Upgrade
|
| Cash Interest Paid | - | 0.36 | 0.4 | 0.42 | 0.39 | 0.64 | Upgrade
|
| Cash Income Tax Paid | - | 2.1 | 2.4 | 2.3 | 2.71 | 3.28 | Upgrade
|
| Levered Free Cash Flow | - | -21.71 | 19.89 | -0.62 | -4.6 | 0.61 | Upgrade
|
| Unlevered Free Cash Flow | - | -21.48 | 20.14 | -0.36 | -4.36 | 1.01 | Upgrade
|
| Change in Working Capital | - | -29.19 | 10.52 | -10.47 | -13.97 | -6.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.